Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rémi Bourdais"'
Autor:
Rémi Bourdais, Samir Achkar, Charles Honoré, Matthieu Faron, Andrea Cavalcanti, Guillaume Auzac, Carine Ngo, Leila Haddag-Miliani, Benjamin Verret, Sarah Dumont, Eric Deutsch, Axel Le Cesne, Olivier Mir, Cécile Le Péchoux, Antonin Levy
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 79-84 (2021)
Aim: To prospectively assess toxicities of curative-intent intensity-modulated conformal radiotherapy (IMRT) in patients with extremity soft tissue sarcomas (ESTS). Methods: Data from 59 consecutive patients with ESTS between 2014 and 2019 were both
Externí odkaz:
https://doaj.org/article/795fc0cca8cf4bf3a5e7347ebe06bd0f
Autor:
Rémi Bourdais, Samir Achkar, Sophie Espenel, Sophie Bockel, Laetitia Chauffert-Yvart, Florence Ravet de Mellis, Minh-Hanh Ta, Wassila Boukhelif, Jérôme Durand-Labrunie, Pascal Burtin, Christine Haie-Meder, Eric Deutsch, Cyrus Chargari
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 263-272 (2021)
Externí odkaz:
https://doaj.org/article/47b39b8fcd39462ab080306b600c3793
Autor:
Axel Cailleteau, Philippe Maingon, Sylvain Choquet, Rémi Bourdais, Delphine Antoni, Bruno Lioure, Cyrille Hulin, Stéphanie Batard, Camille Llagostera, Valentine Guimas, Cyrille Touzeau, Philippe Moreau, Marc-André Mahé, Stéphane Supiot
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:677-685
A second intensification is an option at first relapse in multiple myeloma (MM) after more than 36 months of initial remission. Many conditioning regimens have been tested, with or without total body irradiation (TBI). Recently, it was found that TBI
Autor:
Guillaume Rougier, Adrien Rochand, Rémi Bourdais, Nicolas Meillan, Frédéric Tankere, Philippe Herman, François Riet, Jean‐Jacques Mazeron, Nelly Burnichon, Charlotte Lussey‐Lepoutre, Julian Jacob, Jean‐Marc Simon, Philippe Maingon, Loïc Feuvret
Publikováno v:
The Laryngoscope. 133:607-614
HeadNeck Paragangliomas have been historically relying on surgery mostly, with worsened quality of life and major sequelae. Conventional external radiation therapy seems to offer an equivalent control rate with a low toxicity profile. The aim of this
Autor:
Anne-Sophie Duhamel, Edouard Romano, Minh-Hanh Ta, Arthur Pounou, Cyrus Chargari, Bernard Celestin, Mickaël Andraud, Rémi Bourdais, Lauriane Bordenave, Geoffroy Boulle, T. Kumar, S. Achkar, M. Kissel, Christine Haie-Meder, Valérie Billard
Publikováno v:
Brachytherapy. 19:462-469
Implantations for uterovaginal brachytherapy are usually performed under general or spinal anesthesia, which are not without risk. As it is a rather short procedure and since postoperative pain is minimal, hypnosedation was proposed to selected patie
Autor:
C. Haie-Meder, Sophie Bockel, Sophie Espenel, Eric Deutsch, Laetitia Chauffert-Yvart, Jérôme Durand-Labrunie, S. Achkar, Minh-Hanh Ta, Pascal Burtin, Florence Ravet de Mellis, Wassila Boukhelif, Rémi Bourdais, Cyrus Chargari
Publikováno v:
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 263-272 (2021)
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 263-272 (2021)
Purpose To examine clinical outcomes and quality of life of patients with anal squamous cell carcinoma treated with interstitial pulsed-dose-rate brachytherapy (PDR-BT) with a boost to residual tumor after external radiotherapy. Material and methods
Autor:
Antonin, Levy, Charles, Honoré, Sarah, Dumont, Rémi, Bourdais, Andréa, Cavalcanti, Matthieu, Faron, Carine, Ngo, Leila, Haddag-Miliani, Axel, Le Cesne, Olivier, Mir, Cécile, Le Péchoux
Publikováno v:
Bulletin du cancer. 108(9)
Radiation therapy is a standard treatment for limbs soft tissue sarcomas. Preoperative versus postoperative radiotherapy has been a controversial topic for years. With preoperative irradiation, the treatment volume is more limited, the delivered dose
Autor:
Rémi Bourdais, Aude Guillemin, Christophe Tournigand, Cindy Neuzillet, Isabelle Baumgaertner, Helene Boussion, Charlotte Joly, Anaïs Pujals, Benoit Rousseau
Publikováno v:
Critical reviews in oncology/hematology. 113
Immune checkpoint inhibition is a new therapeutic strategy that has shown promising efficacy in many cancer types. Significant activity associated with mismatch repair (MMR) deficiency has been observed in hypermutated, microsatellite unstable (MSI)